According to Marksans Pharma 's latest financial reports the company's current earnings (TTM) are $52.37 M. In 2022 the company made an earning of $36.83 M a decrease over its 2021 earnings that were of $39.68 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $52.37 M | 42.19% |
2022 | $36.83 M | -7.19% |
2021 | $39.68 M | 11.01% |
2020 | $35.75 M | 106.32% |
2019 | $17.32 M | 37.56% |
2018 | $12.59 M | 34.07% |
2017 | $9.39 M | 175.18% |
2016 | $3.41 M | -84.8% |
2015 | $22.46 M | -8.77% |
2014 | $24.62 M | 24.52% |
2013 | $19.77 M |